Pi2 Solutions Releases the Latest Version of its Product Literature Database System for the Biopharmaceutical Industry

LONDON, March 1, 2010 /PRNewswire/ -- Pi2 Solutions announces the all-new 2010 version of their world-leading Product Literature Database System. This versatile application builds on the success of the 2003 version in use in biopharmaceutical companies around the globe.

In addition to the well-appreciated Guided, Advanced, Author and Thesaurus search interfaces, the new version introduces a number of unique features to aid users of product related information:

    - Customisable Homepages: client administrators can set up multiple
      homepages so users in different pharma regions or therapeutic
      categories can use quick links to access specifically relevant content.
      Users can also configure a personal homepage using drag & drop

    - Variable user rights: different user groups can have restricted views
      on content

    - Current awareness: clickable email alerts for individuals or groups,
      daily, weekly, etc

    - Multiple indexes per article, each index specific to one drug allowing
      pinpoint association of, for example, AE or dosage information, with a
      specific drug

    - Links to full-article versions, according to subscriptions, and to
      various "Related Resources" that cite the literature, such as medical
      letters, monographs and much more

    - Study-specific indexing so that all publications from a given study can
      be quickly recognised and the resulting documentation readily
      downloaded

    - Ability to effortlessly download a Related Resource, its relevant
      bibliographic records and all associated full-articles and other PDFs

    - Complete intra-operability with Pi2's pipeline of downstream workflow
      tools, eg. Pi2's forthcoming software for handling submissions
      reference requests, creating and managing medical letters, the Pi2 KOL
      Db and Pi2 TrialWatch.

    - A new "Copy link" feature which enables pinpoint linking into a
      client's PLD from other client systems and documents.

    - Enhanced custom thesaurus handling capabilities

    - High performance and scalability to >1 million records

The roll-out of the Pi2 2010 PLD version to current clients will be completed in Q2 and new clients will automatically get the upgraded system. Demonstrations to prospective clients will feature the new system together with compatible Pi2 pipeline applications to assist users in their day to day workflow.

Pi2 Product Literature Database (PLD) Systems and Downstream Workflow Applications

Pi2 PLD systems track journal and conference articles that mention a client's drugs and, optionally, those of their competitors. Database records link to the full text articles, to various Related Resources that cite the literature and integrate with a variety of client end-user systems. They typically drive efficiency in an organisation, have a very low ownership cost and generally save a client company many times what they would spend on acquiring a Pi2 PLD. Pi2 PLD systems are widely regarded as being unrivalled in terms of functionality, ease of use and low burden of ownership. Pi2's "Downstream Workflow Applications" will increasingly enable end-users to create and manage their medical letters, create publications planning reports, organise KOLs, as well as tracking clinical trials and medical conferences. Seamless linking between the various Pi2 applications and integration with client internal systems ensure efficiency, greater workflow effectiveness and ease of working.

About Pi2 Solutions Ltd

Pi2 Solutions Ltd is a privately owned London-based company specialising in Product Literature Database (PLD) systems for the biopharmaceutical industry and "Downstream Workflow Applications" for key user groups in functions such as Medical Affairs, Marketing, Drug Safety, Publications Planning, Competitive Intelligence.

Established in 2002, Pi2 has an enviable portfolio of global biopharmaceutical clients from the very largest pharma companies to small emerging biotechs. The strategic aim of Pi2 is to continue to develop solutions for solving the workflow challenges of users of drug-related literature in departments such as libraries/knowledge centres, medical information, medical affairs, publications planning and communications teams, marketing and product strategy, competitive intelligence, drug safety/ pharmacovigilance and others.

For More Information Contact:

[email protected]

SOURCE Pi2 Solutions Ltd